These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 38334078)
21. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine. Grabovac V; Bernkop-Schnürch A Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025 [TBL] [Abstract][Full Text] [Related]
22. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Saremi S; Atyabi F; Akhlaghi SP; Ostad SN; Dinarvand R Int J Nanomedicine; 2011 Jan; 6():119-28. PubMed ID: 21289989 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331 [TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation Li F; Chen X; He Y; Peng Z ACS Appl Bio Mater; 2024 Mar; 7(3):1976-1989. PubMed ID: 38447202 [TBL] [Abstract][Full Text] [Related]
26. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer. Zhang R; Ru Y; Gao Y; Li J; Mao S Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713 [TBL] [Abstract][Full Text] [Related]
27. Thiolated okra chitosan nanoparticles: preparation and optimisation as intranasal drug delivery agents. Brar V; Kaur G J Microencapsul; 2020 Dec; 37(8):624-639. PubMed ID: 33092412 [TBL] [Abstract][Full Text] [Related]
28. Catechol-modified chitosan/hyaluronic acid nanoparticles as a new avenue for local delivery of doxorubicin to oral cancer cells. Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P Colloids Surf B Biointerfaces; 2020 Dec; 196():111279. PubMed ID: 32750605 [TBL] [Abstract][Full Text] [Related]
29. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells. Almutairi FM; Abd-Rabou AA; Mohamed MS Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864 [TBL] [Abstract][Full Text] [Related]
30. CD44 targeted delivery of hyaluronic acid-coated polymeric nanoparticles against colorectal cancer. Phatak N; Bhattacharya S; Shah D; Manthalkar L; Sreelaya P; Jain A Nanomedicine (Lond); 2023 Oct; 18(23):1613-1634. PubMed ID: 37830460 [No Abstract] [Full Text] [Related]
31. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741 [TBL] [Abstract][Full Text] [Related]
32. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201 [TBL] [Abstract][Full Text] [Related]
33. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer. Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841 [TBL] [Abstract][Full Text] [Related]
34. Uniform Core-Shell Nanoparticles with Thiolated Hyaluronic Acid Coating to Enhance Oral Delivery of Insulin. Tian H; He Z; Sun C; Yang C; Zhao P; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y Adv Healthc Mater; 2018 Sep; 7(17):e1800285. PubMed ID: 29984479 [TBL] [Abstract][Full Text] [Related]
35. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity. Hashad RA; Ishak RA; Geneidi AS; Mansour S Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742 [TBL] [Abstract][Full Text] [Related]
36. CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach. Kousar K; Naseer F; Abduh MS; Anjum S; Ahmad T Front Immunol; 2023; 14():1175535. PubMed ID: 37283735 [TBL] [Abstract][Full Text] [Related]
37. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer. Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460 [No Abstract] [Full Text] [Related]
38. Redox/pH-Responsive Biodegradable Thiol-Hyaluronic Acid/Chitosan Charge-Reversal Nanocarriers for Triggered Drug Release. Xia D; Wang F; Pan S; Yuan S; Liu Y; Xu Y Polymers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771342 [TBL] [Abstract][Full Text] [Related]
39. Design and evaluation of hyaluronic acid-coated PLGA nanoparticles of raloxifene hydrochloride for treatment of breast cancer. Bhatt K; Patil P; Jani P; Thakkar P; Sawant K Drug Dev Ind Pharm; 2021 Dec; 47(12):2013-2024. PubMed ID: 35686735 [TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system. Arif M; Raja MA; Zeenat S; Chi Z; Liu C J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]